OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-04-05-accounts

Trust ees' Annual Report ees' Annual Report ees' Annual Report ees' Annual Report for theperiod for theperiod for theperiod
From Period start date To Period end date
1st April 2022 31 March 2023

Trustees' Annual Report for the period

From To

Section A Reference and administration details

Charity name
Other names charity is known by

TREATSMA

Registered charity number (if any)[1182610]

Charity's principal address 85 Great Portland Street First Floor London Postcode W1W 7LT

Names of the charity trustees who manage the charity

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Trustee name Office (if any) Dates acted if not for whole
year
Name of person (or body) entitled
to appoint trustee (ifany)
GENNADIY
ILYASHENKO
JOSEPH IRWIN Resigned November 22
LUCY FROST
ANDI THORNTON
KELLY JONES Resigned November 22
Names of the trustees for the charity, if any, (for example, any custodian trustees)
Name Dates acted if not for whole year

March 2012

TAR

1

Names and addresses of advisers (Optional information)

Type of adviser Name
Address
Name
Address
Name of chief executive or names of senior staff members (Optional information)

Section B Structure, governance and management

Description of the charity’s trusts

Constitution Type of governing document (eg. trust deed, constitution) CIO How the charity is constituted (eg. trust, association, company) Elected by other trustees Trustee selection methods (eg. appointed by, elected by)

Additional governance issues (Optional information)

You may choose to include additional information, where relevant, about:

Section C Objectives and activities

March 2012

TAR

2

Summary of the objects of the
charity set out in its governing
document
Summary of the main activities
undertaken for the public
benefit in relation to these
objects (include within this
section the statutory
declaration that trustees have
had regard to the guidance
issued by the Charity
Commission on public benefit)
We do everything possible to ensure that all people with SMA have
access to effective treatments, health care and social support. We raise
awareness of the disease, offer support to those affected and their near
and dear ones, promote and support scientific research into causes and
treatments, and provide necessary equipment and living aids.

Campaigned for access to treatment of Spinraza, Risdiplam and
Zolgensma.

Worked on Managed Access Program for Spinraza and Risdiplam
together with NHSE and NICE.

Worked with pharmaceutical companies and regulatory agencies
to further knowledge and support the introduction of further
treatments

Collaborated with SMA Reach, SMA Reach Adults and other
Networks.

Ran number of educational webinars for those with and affected by
SMA to help support them on key topics such as:
o
Physiotherapy
o
Respiratory care
o
Standards of care

Provided support to families either by email or telephone as and
when required

Continued fundraising to further our goals

Additional details of objectives and activities (Optional information)

March 2012

TAR

3

You may choose to include further statements, where relevant, about:

Section D Achievements and performance

March 2012

TAR

4

Section D Achievements and performance

Section E Financial review

March 2012

TAR

5

Reserves are carried through to next financial year to support further Brief statement of the advancements in support for the SME community. charity’s policy on reserves

Details of any funds materially in deficit

N/A

Further financial review details (Optional information)

You may choose to include additional information, where relevant about:

The charity’s principal sources of funding is exclusively fundraising and generous donations by individuals. All expenditure is used to support the community and tools required to do so. No money is used in any way as renumeration of the trustees.

Section F Other optional information

Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Dr Gennadiy Ilyashenko Trustee Position (eg Secretary, Chair, etc) Date 20/02/24

March 2012

TAR

6

TAR March 2012

TreatSMA ACCOUNTS 2022-2023

Type of activity Money In
Money Out
Opening balance 19,676.78
Donation: Direct Credit From Amazon Europe Core 38.56
Donation: AFTS Receipt From Bank Leumi UK 15,163.00
Donation: Direct Credit From Amazon Europe Core 33.21
Donation: Direct Credit From Amazon Europe Core 25.96
Donation via PayPal: Direct Credit From Paypal 2,457.23
Donation: Direct Credit From Amazon Europe Core 27.83
Donations: From L Harris 614
Expenses: Reimburmenst to Lucy Frost 204
Expenses: Reimburmenst to Gennadiy Ilyashenko 171.25
Total
End of Year Balance
38,036.57
375.25
37,661.32